Becton, Dickinson and Co., Franklin Lakes, N.J., a developer of cytology imaging systems among an array of medical devices and instruments, has completed the acquisition of Accuri Cytometers, Ann Arbor, Mich., a manufacturer of flow cytometers, computerized devices used to count cells in research and diagnostics, according to a company announcement.
Becton, Dickinson acquires Accuri
“The acquisition of Accuri Cytometers complements and broadens BD's offerings for life scientists by making flow cytometry more accessible to a wider audience of scientists and clinicians,” William Rhodes, president of the BD Biosciences division, said in a statement. “This includes researchers in scientific disciplines that have not traditionally used flow cytometry, such as environmental sciences, microbiology and marine biology.”
Becton, Dickinson announced its intention to buy Accuri in February. Terms were undisclosed.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.